Loading...
Continuous-Infusion Topotecan and Erlotinib: A Study in Topotecan-Pretreated Ovarian Cancer Assessing Shed Collagen Epitopes as a Marker of Invasiveness
BACKGROUND. Continuous-infusion topotecan with erlotinib has the potential to reverse topotecan resistance due to drug efflux mechanisms. We assessed the activity of such a regimen in ovarian cancer patients previously failing bolus topotecan. Assay for shed collagen epitopes recognized by antibody...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AlphaMed Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3958467/ https://ncbi.nlm.nih.gov/pubmed/24563078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0398 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|